JINHAI MED TECH (02225) saw its share price jump more than 11% in morning trading, climbing 10.86% to HK$5.36 at the time of writing, with trading volume reaching HK$11.2177 million.

The surge follows Hang Seng Indexes Company's quarterly review results, which confirmed that changes to the Hang Seng Composite Index will take effect after market close on Friday, September 4, and become active from Monday, September 7. JINHAI MED TECH has been added to the Hang Seng Composite Index, positioning it for potential inclusion in the Stock Connect program, as it now meets a range of criteria including market capitalization and liquidity requirements.

Adding to the positive momentum, on August 3, JINHAI MED TECH announced the appointment of Mr. Ma Chengdong as the group's Chief Marketing Officer, effective August 3, 2026, with an initial term of one year. According to the announcement, Mr. Ma will oversee the group's product marketing strategy, market access, academic promotion, and sales and channel operations, while also supervising the commercialization of the group's medical devices and equipment products.